First Time Loading...

Chongkundang Holdings Corp
KRX:001630

Watchlist Manager
Chongkundang Holdings Corp Logo
Chongkundang Holdings Corp
KRX:001630
Watchlist
Price: 61 000 KRW -0.81%
Updated: May 10, 2024

Intrinsic Value

ChongKunDang Holdings Corp. is a business development and investment company, which focuses on pharmaceutical operations. [ Read More ]

The intrinsic value of one Chongkundang Holdings Corp stock under the Base Case scenario is 91 539.52 KRW. Compared to the current market price of 61 000 KRW, Chongkundang Holdings Corp is Undervalued by 33%.

Key Points:
Intrinsic Value
Base Case
91 539.52 KRW
Undervaluation 33%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Chongkundang Holdings Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Chongkundang Holdings Corp stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Chongkundang Holdings Corp

Provide an overview of the primary business activities
of Chongkundang Holdings Corp.

What unique competitive advantages
does Chongkundang Holdings Corp hold over its rivals?

What risks and challenges
does Chongkundang Holdings Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Chongkundang Holdings Corp.

Provide P/S
for Chongkundang Holdings Corp.

Provide P/E
for Chongkundang Holdings Corp.

Provide P/OCF
for Chongkundang Holdings Corp.

Provide P/FCFE
for Chongkundang Holdings Corp.

Provide P/B
for Chongkundang Holdings Corp.

Provide EV/S
for Chongkundang Holdings Corp.

Provide EV/GP
for Chongkundang Holdings Corp.

Provide EV/EBITDA
for Chongkundang Holdings Corp.

Provide EV/EBIT
for Chongkundang Holdings Corp.

Provide EV/OCF
for Chongkundang Holdings Corp.

Provide EV/FCFF
for Chongkundang Holdings Corp.

Provide EV/IC
for Chongkundang Holdings Corp.

Show me price targets
for Chongkundang Holdings Corp made by professional analysts.

What are the Revenue projections
for Chongkundang Holdings Corp?

How accurate were the past Revenue estimates
for Chongkundang Holdings Corp?

What are the Net Income projections
for Chongkundang Holdings Corp?

How accurate were the past Net Income estimates
for Chongkundang Holdings Corp?

What are the EPS projections
for Chongkundang Holdings Corp?

How accurate were the past EPS estimates
for Chongkundang Holdings Corp?

What are the EBIT projections
for Chongkundang Holdings Corp?

How accurate were the past EBIT estimates
for Chongkundang Holdings Corp?

Compare the revenue forecasts
for Chongkundang Holdings Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Chongkundang Holdings Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Chongkundang Holdings Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Chongkundang Holdings Corp compared to its peers.

Compare the P/E ratios
of Chongkundang Holdings Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Chongkundang Holdings Corp with its peers.

Analyze the financial leverage
of Chongkundang Holdings Corp compared to its main competitors.

Show all profitability ratios
for Chongkundang Holdings Corp.

Provide ROE
for Chongkundang Holdings Corp.

Provide ROA
for Chongkundang Holdings Corp.

Provide ROIC
for Chongkundang Holdings Corp.

Provide ROCE
for Chongkundang Holdings Corp.

Provide Gross Margin
for Chongkundang Holdings Corp.

Provide Operating Margin
for Chongkundang Holdings Corp.

Provide Net Margin
for Chongkundang Holdings Corp.

Provide FCF Margin
for Chongkundang Holdings Corp.

Show all solvency ratios
for Chongkundang Holdings Corp.

Provide D/E Ratio
for Chongkundang Holdings Corp.

Provide D/A Ratio
for Chongkundang Holdings Corp.

Provide Interest Coverage Ratio
for Chongkundang Holdings Corp.

Provide Altman Z-Score Ratio
for Chongkundang Holdings Corp.

Provide Quick Ratio
for Chongkundang Holdings Corp.

Provide Current Ratio
for Chongkundang Holdings Corp.

Provide Cash Ratio
for Chongkundang Holdings Corp.

What is the historical Revenue growth
over the last 5 years for Chongkundang Holdings Corp?

What is the historical Net Income growth
over the last 5 years for Chongkundang Holdings Corp?

What is the current Free Cash Flow
of Chongkundang Holdings Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Chongkundang Holdings Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Chongkundang Holdings Corp

Current Assets 419.7B
Cash & Short-Term Investments 81.1B
Receivables 132B
Other Current Assets 206.5B
Non-Current Assets 1T
Long-Term Investments 481.7B
PP&E 503.9B
Intangibles 27.3B
Other Non-Current Assets 23.4B
Current Liabilities 519.9B
Accounts Payable 62.2B
Accrued Liabilities 14.2B
Short-Term Debt 258.6B
Other Current Liabilities 184.9B
Non-Current Liabilities 373.1B
Long-Term Debt 74.4B
Other Non-Current Liabilities 298.7B
Efficiency

Earnings Waterfall
Chongkundang Holdings Corp

Revenue
879.8B KRW
Cost of Revenue
-495.9B KRW
Gross Profit
383.9B KRW
Operating Expenses
-366.4B KRW
Operating Income
17.4B KRW
Other Expenses
29.6B KRW
Net Income
47B KRW

Free Cash Flow Analysis
Chongkundang Holdings Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

Profitability Score
Profitability Due Diligence

Chongkundang Holdings Corp's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive ROE
Negative 1-Year Revenue Growth
43/100
Profitability
Score

Chongkundang Holdings Corp's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Chongkundang Holdings Corp's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
33/100
Solvency
Score

Chongkundang Holdings Corp's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Chongkundang Holdings Corp

Wall Street analysts forecast Chongkundang Holdings Corp stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Chongkundang Holdings Corp is 71 400 KRW with a low forecast of 70 700 KRW and a high forecast of 73 500 KRW.

Lowest
Price Target
70 700 KRW
16% Upside
Average
Price Target
71 400 KRW
17% Upside
Highest
Price Target
73 500 KRW
20% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Chongkundang Holdings Corp

1M 1M
-1%
6M 6M
+13%
1Y 1Y
+18%
3Y 3Y
-42%
5Y 5Y
-16%
10Y 10Y
+50%
Annual Price Range
61 000
52w Low
46 250
52w High
63 800
Price Metrics
Average Annual Return -2.15%
Standard Deviation of Annual Returns 37.74%
Max Drawdown -65%
Shares Statistics
Market Capitalization 290.4B KRW
Shares Outstanding 4 772 800
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Chongkundang Holdings Corp Logo
Chongkundang Holdings Corp

Country

Korea

Industry

Pharmaceuticals

Market Cap

290.4B KRW

Dividend Yield

0%

Description

ChongKunDang Holdings Corp. is a business development and investment company, which focuses on pharmaceutical operations. The company is headquartered in Seoul, Seoul. Through its subsidiary, the Company provides pharmaceuticals, including remedies for high blood pressure and high cholesterol, immunosuppressive drugs, antitumor agents, antibiotics, remedies for erectile dysfunction and remedies for obesity. The company also produces antitumor agents, antibiotics, digestives, circulation agents, respiratory agents, remedies for endocrine diseases, remedies for skin diseases, functional cosmetics and others, as well as pharmaceutical ingredients. On November 2, 2013, the Company divested its pharmaceutical business into a newly established wholly owned subsidiary. After the divestiture, the Company engages in the investment and holding business.

Contact

SEOUL
Seoul
Chongkundang Bldg., 8, Chungjeong-ro, Seodaemun-gu
+82263730600
http://www.ckdpharm.com/

IPO

1976-06-30

Employees

-

Officers

CEO, President & Chairman of the Board
Tae Young Kim

See Also

Discover More
What is the Intrinsic Value of one Chongkundang Holdings Corp stock?

The intrinsic value of one Chongkundang Holdings Corp stock under the Base Case scenario is 91 539.52 KRW.

Is Chongkundang Holdings Corp stock undervalued or overvalued?

Compared to the current market price of 61 000 KRW, Chongkundang Holdings Corp is Undervalued by 33%.